<PAGE>
AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL 14, 2000
REGISTRATION STATEMENT NO. 333-90399
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------------
POST-EFFECTIVE
AMENDMENT NO. 1 TO
FORM S-3
------------------------------------
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
------------------------------------
MILLENNIUM PHARMACEUTICALS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
------------------------------------
DELAWARE 04-3177038
(STATE OR OTHER JURISDICTION OF (I.R.S. EMPLOYER
INCORPORATION OR ORGANIZATION) IDENTIFICATION NUMBER)
75 SIDNEY STREET
CAMBRIDGE, MASSACHUSETTS 02139
(ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE,
OF REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES)
------------------------------------
MARK J. LEVIN
CHIEF EXECUTIVE OFFICER
MILLENNIUM PHARMACEUTICALS, INC.
75 SIDNEY STREET
CAMBRIDGE, MASSACHUSETTS 02139
(617) 679-7000
(NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE
NUMBER, INCLUDING AREA CODE, OF AGENT FOR SERVICE)
------------------------------------
COPIES TO:
<TABLE>
<S> <C> <C>
DAVID E. REDLICK, ESQ. JOHN B. DOUGLAS III, ESQ. DAVID TRUMMEL, ESQ.
HALE AND DORR LLP MILLENNIUM PHARMACEUTICALS, INC. ELI LILLY AND COMPANY
60 STATE STREET 75 SIDNEY STREET LILLY CORPORATE CENTER
BOSTON, MASSACHUSETTS 02109 CAMBRIDGE, MASSACHUSETTS 02139 INDIANAPOLIS, INDIANA 46286
TELEPHONE: (617) 526-6000 TELEPHONE: (617) 679-7000 TELEPHONE: (317) 276-5669
</TABLE>
<PAGE>
EXPLANATORY NOTE
Pursuant to a Registration Statement (the "Registration Statement") on
Form S-3 (File No. 333-90399), Millennium Pharmaceuticals, Inc. (the
"Registrant") registered shares of its common stock, $.001 par value per share
("Common Stock"), under the Securities Act of 1933, as amended. Pursuant to the
Registrant's undertaking contained in the Registration Statement, this
Post-Effective Amendment No. 1 to Registration Statement on Form S-3 is being
filed solely to remove from registration the shares of Common Stock which remain
unsold under such Registration Statement as of the date of this Post-Effective
Amendment No. 1.
SIGNATURES
Pursuant to Rule 478 promulgated under the Securities Act of 1933, the
Registrant certifies that it has reasonable grounds to believe that it meets the
requirements for filing on Form S-3 and has duly caused this Post-Effective
Amendment No. 1 to Registration Statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the City of Cambridge, Commonwealth
of Massachusetts, on this 14th day of April, 2000.
MILLENNIUM PHARMACEUTICALS, INC.
By: /S/ KEVIN STARR
--------------------------------
KEVIN STARR
Chief Financial Officer
